| scholarly article | Q13442814 |
| P2093 | author name string | Scott E Hensley | |
| Elinor Willis | |||
| P2860 | cites work | Zika virus. I. Isolations and serological specificity | Q22240545 |
| Zika Virus in the Americas — Yet Another Arbovirus Threat | Q22248116 | ||
| Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013 | Q22330748 | ||
| ZIKA VIRUS INFECTION IN MAN. | Q22330885 | ||
| Zika virus infection experimentally induced in a human volunteer | Q22330903 | ||
| Zika Virus Associated with Microcephaly | Q22683189 | ||
| Zika Virus Infection in Pregnant Women in Rio de Janeiro — Preliminary Report | Q23005539 | ||
| Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
| Computed Tomographic Findings in Microcephaly Associated with Zika Virus | Q23756326 | ||
| Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody | Q24067948 | ||
| Zika Virus Associated with Meningoencephalitis | Q24247064 | ||
| Zika Virus Spreads to New Areas - Region of the Americas, May 2015-January 2016 | Q24286939 | ||
| Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes | Q24289053 | ||
| Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention | Q24684689 | ||
| Global spread of dengue virus types: mapping the 70 year history | Q24736362 | ||
| Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus | Q24737245 | ||
| Structural basis of potent Zika–dengue virus antibody cross-neutralization | Q24740325 | ||
| Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus | Q25161212 | ||
| Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro | Q25708158 | ||
| Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection | Q26252507 | ||
| Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control | Q26314452 | ||
| West Nile Virus Encephalitis: The First Human Case Recorded in Brazil | Q26700105 | ||
| Pathogenesis of Dengue: Dawn of a New Era | Q26766198 | ||
| Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification | Q27315772 | ||
| Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus | Q27473186 | ||
| Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites | Q27477542 | ||
| Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein | Q27477718 | ||
| Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease | Q27490947 | ||
| The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 | Q27491317 | ||
| Dengue virus antibodies enhance Zika virus infection | Q28353949 | ||
| Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity | Q29196526 | ||
| Neutralization and antibody-dependent enhancement of dengue viruses | Q29618172 | ||
| Prospects for a dengue virus vaccine | Q29619608 | ||
| IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity | Q33438726 | ||
| Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity | Q34722528 | ||
| Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection | Q37123259 | ||
| Genotype-specific neutralization and protection by antibodies against dengue virus type 3. | Q39668466 | ||
| Structural Basis of Zika Virus-Specific Antibody Protection | Q40056291 | ||
| Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination | Q40140017 | ||
| Dengue Virus-Specific and Flavivirus Group Determinants Identified with Monoclonal Antibodies by Indirect Immunofluorescence | Q40843891 | ||
| Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies | Q40845088 | ||
| Antibody-enhanced dengue virus infection in primate leukocytes | Q40884212 | ||
| The interaction of murine IgG subclass proteins with human monocyte Fc receptors. | Q43618460 | ||
| Antibody formation in cryptogenetic splenomegaly. II. The response to antigen injected subcutaneously | Q95792164 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Zika virus | Q202864 |
| monoclonal antibody | Q422248 | ||
| antibody | Q79460 | ||
| P1104 | number of pages | 6 | |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2017-05-02 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies | |
| P478 | volume | 508 |
| Q47549528 | Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses |
| Q61795493 | Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy |
| Q45324929 | Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge |
| Q91675204 | Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q47550067 | Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice |
| Q50052067 | Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model |
Search more.